Clinical trial · Observational
Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens
NCT01322685CI-TRIAL-00004600unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to study the Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens. Subjects are divided into two groups which are health group and Tuberculosis or lung cancer group in order to compare with the difference.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
| Tuberculosis | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- Health Group
- label
- Tuberculosis Group
- description
- Tuberculosis or lung cancer group
Primary outcomes (0)
[]Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 17 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * Health group: between 17 to 90 years old * Tuberculosis group: people who are tuberculosis or lung cancer patients and between 17 to 90 years old Exclusion Criteria: * Women subjects are before or after the period within two days
References
Publications (0)
Data not yet available
No reference posted for this study.